Trials / Active Not Recruiting
Active Not RecruitingNCT05662345
ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)
ACT-MBC: A Prospective Observational Impact Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 65 (estimated)
- Sponsor
- Menarini Silicon Biosystems, INC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
ACT-MBC prospectively assesses the impact of CTCs on treatment decisions, response assessment and prognosis in MBC patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | CellSearch Circulating Tumor Cells | Serial CTC enumeration |
Timeline
- Start date
- 2022-12-12
- Primary completion
- 2025-11-14
- Completion
- 2026-10-01
- First posted
- 2022-12-22
- Last updated
- 2026-03-17
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05662345. Inclusion in this directory is not an endorsement.